Prescription drug data

The Oregon Prescription Drug Price Transparency program provides the board with prescription drug data submitted under ORS 646A.689 (2) and (6), and ORS 743.025. Information about insulin comes from the Oregon Health Authority’s All Payer All Claims (APAC) reporting program. Information is aggregated and de-identified. The board strictly maintains the confidentiality of any information collected, used or relied upon for the review that is protected trade secret, confidential, or proprietary information, as defined in ORS 192.345.

2025 Affordability review data information (using 2023 data)

June 18, 2025 board meeting